Clinical Trials Browser

Phase 2 × Melanoma × tilsotolimod × Clear all

NCT02644967 2022-08-03

ILLUMINATE-204

Phase 2 Completed

53 enrolled 21 charts

Melanoma

NCT04126876 2021-04-15

INTRIM

Phase 2 Recruiting

Melanoma